相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。LncRNA DANCR promotes cervical cancer progression by upregulating ROCK1 via sponging miR-335-5p
Huiling Liang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
DANCR contributed to hepatocellular carcinoma malignancy via sponging miR-216a-5p and modulating KLF12
Jianchu Wang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
The long non-coding RNA-DANCR exerts oncogenic functions in non-small cell lung cancer via miR-758-3p
Sheng Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Overexpression of lncRNA DANCR positively affects progression of glioma via activating Wnt/β-catenin signaling
Jun Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
EVEGF and SEMA4D have synergistic effects on the promotion of angiogenesis in epithelial ovarian cancer
Ying Chen et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2018)
Long noncoding RNA DANCR aggravates retinoblastoma through miR-34c and miR-613 by targeting MMP-9
Jing-Xian Wang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Long noncoding RNA DANCR mediates cisplatin resistance in glioma cells via activating AXL/PI3K/Akt/NF-κB signaling pathway
Yangang Ma et al.
NEUROCHEMISTRY INTERNATIONAL (2018)
LncRNA DANCR Promotes Lung Cancer by Sequestering miR-216a
Qiang Zhen et al.
CANCER CONTROL (2018)
A new promising way of maintenance therapy in advanced ovarian cancer: a comparative clinical study
Vsevolod I. Kiselev et al.
BMC CANCER (2018)
Long non-coding RNA DANCR regulates proliferation and apoptosis of chondrocytes in osteoarthritis via miR-216a-5p-JAK2-STAT3 axis
Lei Zhang et al.
BIOSCIENCE REPORTS (2018)
Targeting Angiogenesis Taming the Medusa of Ovarian Cancer
Neesha C. Dhani et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2018)
MYC Targeted Long Noncoding RNA DANCR Promotes Cancer in Part by Reducing p21 Levels
Yunqi Lu et al.
CANCER RESEARCH (2018)
Serum Vascular Endothelial Growth Factor-A as a Prognostic Biomarker for Epithelial Ovarian Cancer
Hiroaki Komatsu et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2017)
被撤回的出版物: LncRNA DANCR promotes migration and invasion through suppression of lncRNA-LET in gastric cancer cells (Publication with Expression of Concern. See vol. 40, 2020) (Retracted article. See vol. 40, 2020)
Zhengqiang Mao et al.
BIOSCIENCE REPORTS (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Tumor angiogenesis and vascular normalization: alternative therapeutic targets
Claire Viallard et al.
ANGIOGENESIS (2017)
IncRNA DANCR promotes tumor progression and cancer stemness features in osteosarcoma by upregulating AXL via miR-33a-5p inhibition
Nian Jiang et al.
CANCER LETTERS (2017)
Targeted Therapy of Ovarian Cancer with Angiogenesis Inhibitors
Ping Duan et al.
CURRENT DRUG TARGETS (2017)
Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?
Rakesh R. Ramjiawan et al.
ANGIOGENESIS (2017)
The differential effects of metronomic gemcitabine and antiangiogenic treatment in patient-derived xenografts of pancreatic cancer: treatment effects on metabolism, vascular function, cell proliferation, and tumor growth
Donald T. Yapp et al.
ANGIOGENESIS (2016)
Stressing out over long noncoding RNA
Timothy E. Audas et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2016)
MiR-145 functions as a tumor suppressor via regulating angiopoietin-2 in pancreatic cancer cells
Hao Wang et al.
CANCER CELL INTERNATIONAL (2016)
SARI inhibits angiogenesis and tumour growth of human colon cancer through directly targeting ceruloplasmin
Lei Dai et al.
NATURE COMMUNICATIONS (2016)
Gap junction-mediated transfer of miR-145-5p from microvascular endothelial cells to colon cancer cells inhibits angiogenesis
Dominique Thuringer et al.
ONCOTARGET (2016)
Broad targeting of angiogenesis for cancer prevention and therapy
Zongwei Wang et al.
SEMINARS IN CANCER BIOLOGY (2015)
VEGF and Colon Cancer Growth Beyond Angiogenesis: Does VEGF Directly Mediate Colon Cancer Growth Via a Non-angiogenic Mechanism?
Amrita Ahluwalia et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Treatment options in recurrent ovarian cancer: latest evidence and clinical potential
Daniela Luvero et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2014)
MiR-145 is downregulated in human ovarian cancer and modulates cell growth and invasion by targeting p70S6K1 and MUC1
Huijuan Wu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Downregulation of miR-145 associated with cancer progression and VEGF transcriptional activation by targeting N-RAS and IRS1
Yu Yin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2013)
Down-regulation of miR-145 and miR-143 might be associated with DNA methyltransferase 3B overexpression and worse prognosis in endometrioid carcinomas
Xiaoming Zhang et al.
HUMAN PATHOLOGY (2013)
MiR-145 inhibits tumor angiogenesis and growth by N-RAS and VEGF
Chao Zou et al.
CELL CYCLE (2012)
Suppression of progenitor differentiation requires the long noncoding RNA ANCR
Markus Kretz et al.
GENES & DEVELOPMENT (2012)
分享论文
